Opdivo winning the PD-1 War

[anonymous]

Keep buying those sales! It's the Merck Way! The only Merck Way!

I buy every chance I can!

 

[anonymous]

Just keep feeding the coolaide like Donald: Keytruda will make "patients feel great again!"
We will win, because we are "great" - just like Donald.

 

[anonymous]

Just keep feeding the coolaide like Donald: Keytruda will make "patients feel great again!"
We will win, because we are "great" - just like Donald.

So true. Just stay on message. No matter how bad the message.

 

[anonymous]

I think 60 minutes would love a story about how Pharma is buying Rx scrip again--free vacations, wine and dine. You're all unethical.

 

[anonymous]

• I think 60 minutes would love a story about how Pharma is buying Rx scrip again--free vacations, wine and dine. You're all unethical.

What is the matter? Didn't you get a free lunch today to feed your fat face, buzz off!

 

[anonymous]

It's a foregone conclusion that we're going to lose this battle. The question is how badly.

 

[anonymous]

No, it's Pharma as it used to be played. BTW, what it Keytruda's back-up. BMS has at least two. So with Merck it is one and done. I do not work at Merck, but they treat my friends like crap.

 

[anonymous]

Roger and Ken are going to sink you like the Titanic!

 

[anonymous]

The tailgating will begin early and include the PD1 righters. Booze, food and prizes for all!

 

[anonymous]

The tailgating will begin early and include the PD1 righters. Booze, food and prizes for all!

Just left the bedroom! After a raucously enjoyable weekend of selling!
Oh the product to be utilized. Winner once again!

 

[anonymous]

It's not a war. It's a slaughter. We'll end up with 10% of the market if we're lucky.

 

[anonymous]

It's not a war. It's a slaughter. We'll end up with 10% of the market if we're lucky.

Get your faggy ass off our site!

 

[anonymous]

It's not a war. It's a slaughter. We'll end up with 10% of the market if we're lucky.

I just saw Opdivo received kidney cancer indication. Looks like they are running away with different indications earlier than we thought. This can hurt our share. Does anyone know what new indications to come with our drug in the near future?

 

[anonymous]

I just saw Opdivo received kidney cancer indication. Looks like they are running away with different indications earlier than we thought. This can hurt our share. Does anyone know what new indications to come with our drug in the near future?

Sell what you have and shutup. Get the deli in early then leave!

 

[anonymous]

It's not a war. It's a slaughter. We'll end up with 10% of the market if we're lucky.

That is correct.

 

[anonymous]

That is correct.

I actually sell my product, I don't wait for others to pull the wagon. Also, I lead the nation in sales and off label usage.

 

[anonymous]

I actually sell my product, I don't wait for others to pull the wagon. Also, I lead the nation in sales and off label usage.

Selling at lunch today. Holding a journal club at the Country Club and supplying top menu choices and libations of choice. Let no stone unturned!

 

[anonymous]

I just saw Opdivo received kidney cancer indication. Looks like they are running away with different indications earlier than we thought. This can hurt our share. Does anyone know what new indications to come with our drug in the near future?

Approved two days ago for BRAF metatastic melanoma.

 

[anonymous]

Get your faggy ass off our site!

Methinks somebody is scared, jealous or both.

 

[anonymous]

Up early and hitting the links with Chief of Oncology. That is how to sell / relationship.